essential clinical epidemiology randomized controlled
play

Essential Clinical Epidemiology Randomized Controlled Trial Anna - PowerPoint PPT Presentation

Essential Clinical Epidemiology Randomized Controlled Trial Anna Keski-Rahkonen Pyry Sipil Clinicum, Department of Public Health Randomly generated celebrity faces Video Some solutions to homework puzzles commons.wikimedia.org God


  1. Essential Clinical Epidemiology Randomized Controlled Trial Anna Keski-Rahkonen Pyry Sipilä Clinicum, Department of Public Health

  2. Randomly generated celebrity faces Video

  3. Some solutions to homework puzzles commons.wikimedia.org

  4. “God doesn't play dice with the universe.” Albert Einstein Want to know more about God playing dice with the universe?

  5. RCT, Basic Study Design Treatment Group Control Group Outcome Outcome YES NO YES NO Slide adapted from Lorraine Alexander & Karen Yeatts

  6. Randomization • Sound randomization will on average distribute all known and unknown confounding factors equally to different arms (groups) of the study. • This can be affected by chance, of course.

  7. The Cult of the RCT

  8. RCT – common problems • Something goes wrong with the randomization • Intention to treat analysis not conducted

  9. Allocation concealment DATA CENTER Making sure that randomization will occur -> Removing selection bias

  10. Who is Blind? Participant Researcher Data Analyst

  11. Intention to Treat, Basic Principle:

  12. ITT • Anything nonrandom (completion of study, problems in allocaion concelment etc. etc.) will make the RCT an observational study. • An observational study in the disguise of RCT has all the pitfalls of any other observational study - and potentially worse. • RCTs have usually not been designed to adequately control for confounding.

  13. RCTs, Advantages & Disadvantages • Advantages: • unbiased distribution of confounders; • blinding more likely; • randomisation facilitates statistical analysis. • Disadvantages: • expensive: time and money; • volunteer bias; • ethically problematic at times. Slide: Oxford University, Centre for Evidence-Based Medicine

  14. “All RCTs do is show that what you’re dealing with is not snake oil.” Ben Williams

  15. PI CO Que stio ns • P = Pa tie nt / Pro b le m • I = I nte rve ntio n • C = Co mpa riso n/ Co ntro l • O = Outc o me

  16. What is a Large Effect? Effect Sizes: Cohen’s d • Cohen classified effect sizes as • small ( d = 0.2), • medium ( d = 0.5), and • large ( d ≥ 0.8). 5 • “A medium effect of .5 is visible to the naked eye of a careful observer. A small effect of .2 is noticeably smaller than medium but not so small as to be trivial. A large effect of .8 is the same distance above the medium as small is below it.” https://youtu.be/0sSHqWzqq -I

  17. Visualize with your pair using bit.do/effectsize How the distributions in the intervention and control group differ • small ( d = 0.2), • medium ( d = 0.5), and • large ( d ≥ 0.8). • “A medium effect of .5 is visible to the naked eye of a careful observer. A small effect of .2 is noticeably smaller than medium but not so small as to be trivial. A large effect of .8 is the same distance above the medium as small is below it.”

  18. Power Calculations https://youtu.be/P2Z6u8hwl2U

  19. Practical Problem Observational studies: Low levels of serum Vitamin D3 -> more cancer & cardiovascular disease cancer↓ ? → cardiovascular disease↓ ?

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend